Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a dashboard turn patient data into better arthritis care?

NCT ID NCT07782541

Knowledge-focused Sponsor: Royal United Hospitals Bath NHS Foundation Trust Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 24, 2026 · Last updated Aug 25, 2026 · Updated 1 time

Summary

This study explores how a clinical dashboard can present patient-generated health data—like symptoms and activity tracked on smartphones or wearables—to improve care for axial spondyloarthritis (axSpA). Researchers will observe consultations and interview patients and clinicians to understand how the dashboard is used and what barriers exist. Through co-design workshops, they will gather input on how to optimize the platform and whether predictive analytics could add value. The goal is to make patient-clinician collaboration more insightful and care more efficient.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A clinical dashboard for presenting patient-generated health data
What this could lead to
If successful, this could lead to better use of patient-generated health data in routine care, improving patient-clinician collaboration and care efficiency for chronic conditions like axSpA.
What could go wrong
This is a small, early-stage study focused on design and usability, not clinical outcomes. The dashboard may not be widely adopted or may not improve care as hoped.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

17 people

The number who actually took part.

Started

Feb 2026

Finished

Jul 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients treated for axSpA at RUH

Ages

18 years and older

Sex

Anyone

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults over 18 with a diagnosis of axSpA * Treated at the Royal National Hospital for Rheumatic Diseases, at the Royal United Hospitals Bath NHS Foundation Trust * Due to have a planned consultation during the study period * If participating in the interview via Teams, access to an electronic device (computer, laptop, tablet, or smartphone) and email address is required. If participating over the phone or via Teams, a quiet, private space is required to conduct the interview. Exclusion Criteria: \- The person believes that participation may cause them to feel distress, discomfort or embarrassment.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Axial spondylarthritis (axspa) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ankylosing spondylitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Axial spondylarthritis (axspa)

Contacts and locations

Locations

  • Royal National Hospital for Rheumatic Diseases, at the Royal United Hospitals Bath NHS Foundation Trust

    Bath, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.